Abstract
We report our experience with the combination of anti-thymocyte globulin (ATGAM) and tacrolimus in the treatment of 20 patients with steroid refractory and dependent acute graft-versus-host disease (GVHD) transplanted between August 1996 and February 2000. All patients received cyclosporine-based GVHD prophylaxis. Thirteen patients developed a maximum of grade IV, five grade III and two grade II acute GVHD, with 15 patients being refractory to steroids and five dependent on steroids. Patients were treated with ATGAM (15 mg/kg for 5 d) and tacrolimus (0.025--0.1 mg/kg/d) in addition to continuation of their high-dose steroids and cessation of their cyclosporine. Within 28 d of treatment, we observed eight complete responses (CR), six partial responses (PR) and six with no response. Overall response (CR + PR) was predicted by GVHD severity. Infectious complications occurred in 80% of patients. The median survival was 86.5 d (range, 21--1081 d) with 35% of patients remaining alive. Survival following combination therapy was significantly more likely in men (P < 0.001), skin-only GVHD (P = 0.027), less severe GVHD (P = 0.048), and in responders to tacrolimus and ATGAM (P < 0.001). In conclusion, concurrent introduction of ATGAM and...Continue Reading
References
Jan 1, 1992·Bone·S E HaynesworthA I Caplan
Feb 1, 1991·Annals of Neurology·A Tessler
Mar 20, 1986·The New England Journal of Medicine·R StorbV Farewell
Oct 1, 1974·Transplantation·H GlucksbergE D Thomas
Jan 1, 1981·American Journal of Hematology·K C DoneyE D Thomas
Sep 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J B Weaver
Sep 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J D Van HornJ M Maisog
Sep 23, 1995·Lancet·H E HeslopR Billing
Oct 19, 1995·The New England Journal of Medicine·E A WalterS R Riddell
Aug 27, 1994·Transplantation·I M HingsD J Weisdorf
Feb 1, 1993·Transplantation Proceedings·E W PetersdorfJ A Hansen
Nov 1, 1995·Bone·R W NorrdinM A Thrall
Mar 2, 1997·Bone Marrow Transplantation·Y OhashiT Konno
Jul 1, 1997·Annals of Hematology·M J DuganD J Weisdorf
Jul 25, 1998·Bone Marrow Transplantation·N BasaraA A Fauser
Aug 28, 1998·Bone Marrow Transplantation·P JacobsonV Ratanatharathorn
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·W R KirkpatrickT F Patterson
Citations
Dec 20, 2002·Clinics in Dermatology·Vincenzo RuoccoRonni Wolf
Jun 9, 2005·Transplantation·Martin S ZandBenjamin J Briggs
May 1, 2007·Clinical Pharmacokinetics·Céline DartoisPascal Girard
Jan 25, 2005·American Journal of Clinical Dermatology·Pablo F PeñasAmaro García-Diez
May 31, 2014·Immunobiology·Lauriane PadetRenée Bazin
Nov 26, 2010·Transplantation Proceedings·A J OsbandR A Mann
Mar 16, 2007·British Journal of Haematology·Edward S Morris, Geoffrey R Hill
Nov 6, 2015·Indian Journal of Dermatology·Pushpa Kodipalya RamakrishnaiahNataraja Holavanahally Veerabhadrappa
Apr 19, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul J MartinPaul A Carpenter
Jan 27, 2012·Leukemia Research·Wei WeiJian Hou
May 16, 2006·Bone Marrow Transplantation·G A KennedyG R Hill
Sep 18, 2014·The Korean Journal of Internal Medicine·Joo Han ParkJoon Seong Park
Jun 7, 2003·Drugs·Lesley J ScottGreg L Plosker
Jan 5, 2002·Seminars in Cutaneous Medicine and Surgery·J Bergman, M J Rico